Eric C. Leas , “The Hemp Loophole: A Need to Clarify the Legality of Delta-8-THC and Other Hemp-Derived Tetrahydrocannabinol Compounds”, American Journal of Public Health 111, no. 11 (November 1, 2021): pp. 1927-1931. https://doi.org/10.2105/AJPH.2021.306499 

Leas EC, Nobles AL, Shi Y, Hendrickson EM, Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use, International Journal of Drug Policy, 2022. https://doi.org/10.1016/j.drugpo.2021.103557

Leas EC, Moy N, McMenamin SB, Shi Y, Benmarhnia T, Stone MD, Trinidad DR, White M. Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops. Int J Env Res Pub He. 2021 Jan;18(13):6719. https://doi.org/10.3390/ijerph18136719

Leas EC, Hendrickson EM, Nobles AL, Todd R, Smith DM, Dredze M, Ayers JW. Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies. JAMA Netw Open. 2020. 3(10):e2020977. https://doi.org/10.1001/jamanetworkopen.2020.20977

Selected News Coverage: US News & World Report

Also read NIDA deputy director Dr. Wilson Compton and Science Policy Branch Chief Dr. Emily Einstein's invited commentary on this publication.

Leas EC, Nobles AL, Caputi T, Dredze M, Smith D, Ayers JW, Trends in Internet Searches for Cannabidiol (CBD) in the United States, JAMA Open, 2019, 2(10):e1913853-. https://doi.org/10.1001/jamanetworkopen.2019.13853

Selected News Coverage: STAT News | Washington Post 

Leas EC, Hendrickson EM, Nobles AL, Todd R, Smith DM, Dredze M, Ayers JW. Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies. JAMA Netw Open. 2020. 3(10):e2020977. https://doi.org/10.1001/jamanetworkopen.2020.20977

Selected News Coverage: New York Times | San Diego Union Tribune